CAS 2092925-89-6

Palazestrant

CAS: 2092925-89-6

Palazestrant

Reinheit: ≥95%

Molekulargewicht: 449.6g/mol

Ref: 54-BUP01207

Palazestrant

CAS: 2092925-89-6

Palazestrant, an antiestrogen and antineoplastic agent, effectively targets ER+/HER2+ cancer when used in conjunction with a HER2 inhibitor.

Formel: C₂₈H₃₆FN₃O

Reinheit: 97.55%

Farbe und Form: Solid

Molekulargewicht: 449.6

Ref: TM-T72945